Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

66 projects found matching your search criteria :

  1. Targeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease

    Call: OPUS 9 , Panel: NZ2

    Principal investigator: prof. Johannes Antonius Bluijssen (Bluyssen)

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  2. Aromatic aminotransferases from Candida albicans as molecular targets for antifungal chemotherapy.

    Call: OPUS 9 , Panel: NZ6

    Principal investigator: dr Iwona Aniela Gabriel

    Politechnika Gdańska, Wydział Chemiczny

  3. Mechanisms underlying the targeting of coding sequence repeats by microRNA-like inhibitors

    Call: OPUS 8 , Panel: NZ1

    Principal investigator: dr Agnieszka Fiszer

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  4. Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic m...

    Call: HARMONIA 6 , Panel: NZ5

    Principal investigator: dr Tomasz Artur Stokłosa

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  5. Hydrogel microspheres containing dextran-based nanoparticles. Study on targeting effect in novel anticancer drug deliver...

    Call: PRELUDIUM 7 , Panel: NZ5

    Principal investigator: Aleksandra Anna Kulikowska

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

  6. Analysis of relations on the level of metabolome, miRNome, and transcriptome of human renal cancer: towards identificati...

    Call: OPUS 7 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Piekiełko-Witkowska

    Centrum Medyczne Kształcenia Podyplomowego

  7. Targeted genomics of cardiovascular disease - multivariable genetic model of perioperative and long-term cardiovascular ...

    Call: OPUS 5 , Panel: NZ5

    Principal investigator: prof. Marek Jan Sanak

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

  8. Characteristics of the cell wall hydrolases of pathogenic bacteria Listeria monocytogenes and their partcipation in the ...

    Call: OPUS 5 , Panel: NZ6

    Principal investigator: dr hab. Magdalena Anna Popowska

    Uniwersytet Warszawski, Wydział Biologii

  9. Identification of triple negative breast cancer with inactive DNA damage repair pathway by homologous recombination base...

    Call: SONATA 3 , Panel: NZ5

    Principal investigator: dr Paweł Wenancjusz Domagała

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim

  10. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  11. Identifying early biomarkers and molecular targets for therapeutic intervention in right ventricular dysfunction

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Przemysław Błyszczuk

    Uniwersytet Jagielloński

  12. Molecular insights into NAD+ metabolism in Huntington's disease: role in pathophysiology and preclinical assessment of t...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr hab. Marta Urszula Tomczyk

    Gdański Uniwersytet Medyczny

  13. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

  14. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: Kamila Ostrowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  15. Identification of circulating biomarkers for monitoring anti-CD19 CAR-T cell treatment response in patients with aggress...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Monika Szelest

    Uniwersytet Medyczny w Lublinie

  16. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Katarzyna Anna Malarz

    Politechnika Śląska

  17. Proteomic predictors of metastasis in colorectal cancer – a validation study

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Anna Wojakowska

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  18. Exploring genetic resources of flax via genetic and metabolic markers as a means for targeted breeding towards improved ...

    Call: OPUS 27 , Panel: NZ9

    Principal investigator: dr hab. Anna Małgorzata Kulma

    Uniwersytet Wrocławski

  19. CD147 as a novel multifunctional modulator of podocyte metabolism and exosome biogenesis: Identification of new molecula...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: dr hab. Agnieszka Piwkowska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  20. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  21. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  22. Dissecting the regulatory interplay between proteases and protein kinases in acute lymphoblastic leukemia using mass cyt...

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  23. Customized DNA-based nanocarriers to boost heart healing

    Call: WEAVE-UNISONO , Panel: NZ7

    Principal investigator: dr Monika Bzowska

    Uniwersytet Jagielloński

  24. Investigating the role of fibroblast growth factor receptors and STAT transcription factors in the targeted therapy of a...

    Call: PRELUDIUM BIS 4 , Panel: NZ5

    Principal investigator: prof. Ewa Teresa Marcinkowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  25. Modifiers of Muscleblind-like genes expression in health and disease.

    Call: SONATA BIS 12 , Panel: NZ5

    Principal investigator: dr hab. Ewa Agnieszka Stępniak-Konieczna

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Rolnictwa, Ogrodnictwa i Biotechnologii

  26. Targeting of metabolic and transcriptomic cross-talk between leukemic cells and macrophages as a therapeutic strategy in...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Baran Natalia

    Instytut Hematologii i Transfuzjologii

  27. Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell the...

    Call: PRELUDIUM BIS 3 , Panel: NZ5

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

  28. Studies on the prevalence and properties of peptidoglycan peptidases as potential antimicrobial agents with targeted spe...

    Call: OPUS 22 , Panel: NZ6

    Principal investigator: dr hab. Benedykt Władyka

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  29. The role of NPM1 as biomarker of the targeted therapy efficacy in chronic lymphocytic leukemia patients

    Call: PRELUDIUM BIS 3 , Panel: NZ5

    Principal investigator: prof. Krzysztof Georgios Giannopoulos

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

  30. Role of RelA(p65) and cRel phosphorylations and their kinases in the biology of Diffuse-large B-cell lymphoma and Hodgki...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Maciej Stefan Szydłowski

    Instytut Hematologii i Transfuzjologii

  31. In the search of specific oxylipin fingerprint reflecting the development of endothelial dysfunction with the use of non...

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Agnieszka Róża Kij

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  32. Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Natalia Vydra

    Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy, Oddział w Gliwicach

  33. Searching for new therapeutic targets in polyglutamine diseases

    Call: OPUS 22 , Panel: NZ2

    Principal investigator: dr hab. Marta Olejniczak

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  34. The biological role of sRNA OmrA and its impact on the level of virulence and adaptability of Yersinia enterocolitica en...

    Call: PRELUDIUM BIS 3 , Panel: NZ6

    Principal investigator: dr hab. Adrianna Dorota Raczkowska

    Uniwersytet Warszawski, Wydział Biologii

  35. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Anna Piotrowska-Murzyn

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  36. Mechanisms involved in heme acquisition - potential targets for therapies directed towards reduction of Porphyromonas gi...

    Call: OPUS 21 , Panel: NZ6

    Principal investigator: dr Michał Sylwester Śmiga

    Uniwersytet Wrocławski, Wydział Biotechnologii

  37. MicroRNAome maturation control and its application in selective targeting of cancer stem cells

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: dr Jakub Godlewski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  38. Identification of the interdependence between SWI/SNF-type chromatin remodeling complex, metabolism control and RNA modi...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: prof. Tomasz Jacek Sarnowski

    Instytut Biochemii i Biofizyki Polskiej Akademii Nauk

  39. Identification of surface proteins as alternate targets for CAR-T therapy against CD19-negative tumors.

    Call: PRELUDIUM BIS 2 , Panel: NZ6

    Principal investigator: dr hab. Magdalena Hanna Winiarska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  40. The use of surface proteins to capture cancer cells with functionalized magnetic nanoparticles as an innovative theranos...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: dr hab. Joanna Danuta Dulińska-Litewka

    Uniwersytet Jagielloński, Wydział Chemii

  41. Identification of potential markers aiming early diagnostics of progression and tailoring metastasis-oriented therapies ...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: dr Natalia Bednarz-Knoll

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  42. Toxic RNA with expanded trinucleotide repeats: pathomechanism and therapeutic targets of neurological diseases

    Call: MAESTRO 12 , Panel: NZ3

    Principal investigator: prof. Krzysztof Sobczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  43. Modulation of immune cells activity in the tumor microenvironment by oligonucleotide therapeutics delivered by silk nano...

    Call: OPUS 19 , Panel: NZ6

    Principal investigator: prof. Hanna Dams-Kozłowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  44. Atopic Dermatitis - searching for new strategic points of treatment, by evaluating clinical and prognostic significance ...

    Call: PRELUDIUM 19 , Panel: NZ5

    Principal investigator: Anna Maria Zaryczańska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  45. New multifunctional drug-like ligands focusing on molecular targets associated with the symptoms and causes of Alzheimer...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Anna Marta Pasieka

    Uniwersytet Jagielloński, Collegium Medicum

  46. Understanding of the mesenchymal stem cells (MSCs)-mediated immune suppression mechanism in the neutrophilic experimenta...

    Call: PRELUDIUM 19 , Panel: NZ5

    Principal investigator: dr Marlena Tynecka

    Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim

  47. New insights into multifaceted targeted therapy for treatment of glioblastoma multiforme.

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr Katarzyna Anna Malarz

    Uniwersytet Śląski w Katowicach, Wydział Nauk Ścisłych i Technicznych

  48. Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic ...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Zofia Kuter-Nowak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  49. The 'omics' of renal cancer nucleolus: towards identification of new cancer markers and therapeutic targets.

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: prof. Agnieszka Piekiełko-Witkowska

    Centrum Medyczne Kształcenia Podyplomowego, Szkoła Nauk Medycznych

  50. Concomitant IDentification and Antibiotic REsistance profile of bacteria in one hour with an adaptive targeted single Ma...

    Call: CHIST-ERA2018 , Panel: NZ6

    Principal investigator: prof. Marek Tomasz Gniadkowski

    Narodowy Instytut Leków